AbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023
11 Octubre 2023 - 3:05PM
Business Wire
AbCellera (Nasdaq: ABCL) will announce its third quarter 2023
financial results on Thursday, November 2, 2023, and hold an
earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m.
Eastern Time) the same day.
A live audio webcast of the earnings conference may be accessed
through a link that will be posted on AbCellera’s Investor
Relations website. A replay will be available through the same link
following the conference call.
About AbCellera Biologics Inc. AbCellera is breaking the
barriers of conventional antibody discovery to bring better
medicines to patients, sooner. AbCellera’s engine integrates expert
teams, technology, and facilities with the data science and
automation needed to propel antibody-based medicines from target to
clinic in nearly every therapeutic area with precision and speed.
AbCellera provides innovative biotechs and leading pharmaceutical
companies with a competitive advantage that empowers them to move
quickly, reduce cost, and tackle the toughest problems in drug
development. For more information, please visit
www.abcellera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231010770000/en/
Inquiries Media: Jessica Yingling, Ph.D.;
media@abcellera.com, +1(236)521-6774 Business Development: Murray
McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005 Investor
Relations: Josephine Hellschlienger, Ph.D.; ir@abcellera.com,
+1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
AbCellera Biologics (NASDAQ:ABCL)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024